Circulating metabolic profile in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Please find below a podcast of Dr Jamie Todd discussing some new data from the IPF-PRO Registry on associations between circulating metabolites and disease severity and outcomes in patients with idiopathic pulmonary fibrosis.

microphone
 
Header - Navigation Icon

The IPF-PRO/ILD-PRO Registry is supported by Boehringer Ingelheim Pharmaceuticals, Inc (BIPI) and run in collaboration with the Duke Clinical Research Institute (DCRI) and enrolling centers. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for development of this podcast or the manuscript on which it is based. Editorial support on the article and podcast was provided by Fleishman-Hillard, London, UK, which was contracted and funded by BIPI. BI was given the opportunity to review the manuscript and podcast for medical and scientific accuracy as well as intellectual property considerations.